Safety evaluation of Tibetan medicine Qishiwei Zhenzhu Pills based on serum pharmacochemistry and network pharmacology.
10.19540/j.cnki.cjcmm.20230203.501
- Author:
Zhi-Yi YAN
1
;
Yong-Hua ZONG
2
;
Cheng-Fei ZHANG
3
;
Li-Li WU
3
;
Ling-Ling QIN
3
;
Tong-Hua LIU
3
Author Information
1. Dongfang Hospital, Beijing University of Chinese Medicine Beijing 100078, China Key Laboratory of Health-cultivation by Ministry of Education of the People's Republic of China,Beijing University of Chinese Medicine Beijing 100029, China.
2. Department of Tibetan Medicine, University of Tibetan Medicine Lhasa 850000, China Key Laboratory of Health-cultivation by Ministry of Education of the People's Republic of China,Beijing University of Chinese Medicine Beijing 100029, China.
3. Key Laboratory of Health-cultivation by Ministry of Education of the People's Republic of China,Beijing University of Chinese Medicine Beijing 100029, China.
- Publication Type:Journal Article
- Keywords:
Qishiwei Zhenzhu Pills;
molecular docking;
network pharmacology;
serum pharmacochemistry;
zogta
- MeSH:
Animals;
Mice;
Medicine, Tibetan Traditional;
Network Pharmacology;
Molecular Docking Simulation;
Tandem Mass Spectrometry;
Toll-Like Receptor 4;
Medicine, Chinese Traditional;
Mercury;
Drugs, Chinese Herbal/toxicity*
- From:
China Journal of Chinese Materia Medica
2023;48(9):2538-2551
- CountryChina
- Language:Chinese
-
Abstract:
To explore the mechanism of the active ingredients of Qishiwei Zhenzhu Pills in inhibiting the hepatorenal toxicity of the zogta component based on serum pharmacochemistry and network pharmacology, thereby providing references for the clinical safety application of Qishiwei Zhenzhu Pills. The small molecular compounds in the serum containing Qishiwei Zhenzhu Pills of mice were identified by high performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS). Then, by comprehensively using Traditional Chinese Medicines Systems Pharmacology(TCMSP), High-throughput Experiment-and Reference-guided Database(HERB), PubChem, GeneCards, SuperPred, and other databases, the active compounds in the serum containing Qishiwei Zhenzhu Pills were retrieved and their action targets were predicted. The predicted targets were compared with the targets of liver and kidney injury related to mercury toxicity retrieved from the database, and the action targets of Qishiwei Zhenzhu Pills to inhibit the potential mercury toxicity of zogta were screened out. Cytoscape was used to construct the active ingredient in Qishiwei Zhenzhu Pills-containing serum-action target network, and STRING database was used to construct the protein-protein interaction(PPI) network of intersection targets. The Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) enrichment analyses were carried out on the target genes by the DAVID database. The active ingredient-target-pathway network was constructed, and the key ingredients and targets were screened out for molecular docking verification. The results showed that 44 active compounds were identified from the serum containing Qishiwei Zhenzhu Pills, including 13 possible prototype drug ingredients, and 70 potential targets for mercury toxicity in liver and kidney were identified. Through PPI network topology analysis, 12 key target genes(HSP90AA1, MAPK3, STAT3, EGFR, MAPK1, APP, MMP9, NOS3, PRKCA, TLR4, PTGS2, and PARP1) and 6 subnetworks were obtained. Through GO and KEGG analysis of 4 subnetworks containing key target genes, the interaction network diagram of active ingredient-action target-key pathway was constructed and verified by molecular docking. It was found that taurodeoxycholic acid, N-acetyl-L-leucine, D-pantothenic acid hemicalcium, and other active ingredients may regulate biological functions and pathways related to metabolism, immunity, inflammation, and oxidative stress by acting on major targets such as MAPK1, STAT3, and TLR4, so as to inhibit the potential mercury toxicity of zogta in Qishiwei Zhenzhu Pills. In conclusion, the active ingredients of Qishiwei Zhenzhu Pills may have a certain detoxification effect, thus inhibiting the potential mercury toxicity of zogta and playing a role of reducing toxicity and enhancing effect.
